The Pharmaceutical Journal
Vol 274 No 7334 p109
29 January 2005

This article
Reprint   Photocopy

PDF 120K, Acrobat Reader

· Controlled drugs
· Diamorphine shortage (2)
· Medicines information
· Placebo effect
· The Society (16)
· Registration examination (2)
· Dispensing
· We've had enough of...

Letters to the Editor

Controlled drugs

Streamlining the regulatory framework

From Mr N. V. Morley, MRPharmS

C. Ralph (PJ, 15 January, p55) makes a valid point concerning the appropriateness of the classification of scheduled Controlled Drugs. This same point was made by both myself and many other contributors to the Shipman Inquiry and the Controlled Drugs seminars. Indeed, Mr McFarlane, Chief Inspector at the Home Office, stated that a proposal exists to simplify the categorisation and to streamline the regulatory framework.

In addition, the Royal Pharmaceutical Society has indicated that it would welcome a more logical grouping of CDs.

Dame Janet Smith stated in the Shipman Inquiry fourth report that the essential criterion should be: “How great a social evil is the misuse of this drug?” If great, strong regulatory measures are needed. If modest, less regulation is required, she said.

It is my understanding that the appropriate stakeholders are considering this matter in depth.

Nigel Morley
Managing Director
Surelines Pharmaceutical Services Ltd

Send your letter to The Editor

Next Topic (Diamorphine shortage)